Related Experiment Video
Updated: Jul 2, 2026
07:59
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Ultrafiltration for volume control in decompensated heart failure.
Garrie J Haas1, Vincent M Pestritto, William T Abraham
1The Ohio State University Medical Center, Columbus, OH, USA. garrie.haas@osumc.edu
Heart Failure Clinics
|September 2, 2008
Summary
Early implementation of ultrafiltration (UF) may benefit patients with advanced congestion who do not respond to diuretics. Further research is needed to confirm the safety and cost-effectiveness of this approach.
Area of Science:
- Nephrology
- Cardiology
- Critical Care Medicine
Background:
- Advanced congestion is often treated with intravenous diuretics.
- Ultrafiltration (UF) is typically reserved for diuretic-resistant cases.
- Current practice delays UF implementation until later in hospitalization.
Purpose of the Study:
- To explore the potential advantages of earlier UF implementation in hospitalized patients.
- To investigate the safety and cost implications of early UF.
Main Methods:
- This study discusses the potential benefits and challenges of UF.
- It emphasizes the need for further clinical investigation.
- Specific focus on safety and economic factors is recommended.
Main Results:
- Early UF implementation may offer advantages over standard diuretic therapy.
- The current evidence base for early UF is limited.
- Further studies are required to validate these findings.
Conclusions:
- Earlier consideration of ultrafiltration in select patients with advanced congestion warrants investigation.
- Safety and cost-effectiveness are critical factors for future research.
- Optimizing fluid management strategies in advanced congestion is essential.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...